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Objectives: to verify the face validity, criterion-related validity and the reliability of two distinct 
forms of presentation of the instrument Measurement of Adherence to Treatment, one being 
for ascertaining the adherence to the use of oral antidiabetics and the other for adherence to 
the use of insulin, as well as to assess differences in adherence between these two modes of 
drug therapy. Method: a methodological study undertaken with 90 adults with Type 2 Diabetes 
Mellitus. The criterion-related validity was verified using the Receiver Operating Characteristic 
curves; and for the reliability, the researchers calculated the Cronbach alpha coefficient, the 
item-total correlation, and the Pearson correlation coefficient. Results: the oral antidiabetics and 
the other showed sensitivity of 0.84, specificity of 0.35 and a Cronbach correlation coefficient of 
0.84. For the adherence to the use of insulin, the values found were, respectively, 0.60, 0.21 and 
0.68. A statistically significant difference was found between the final scores of the two forms 
of the instrument, indicating greater adherence to the use of insulin than to oral antidiabetics. 
Conclusion: it is concluded that the two forms of the Measurement of Adherence to Treatment 
instrument are reliable and should be used to evaluate adherence to drug treatment among 
people with diabetes mellitus.
Descriptors: Nursing Care; Diabetes Mellitus; Patient Compliance; Validation Studies.
Adherence to treatment for diabetes mellitus: validation
of instruments for oral antidiabetics and insulin1
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Introduction
Adherence to treatment does not refer simply to 
the act of taking the medications; rather, it refers to 
how the person manages their treatment in relation to 
doses, times, frequency and duration(1). In the context 
of chronic illnesses, in which the people and their 
relatives are responsible for the greater part of the care, 
adherence must be seen as a joint activity in which the 
person not only follows medical advice, but understands, 
agrees with and adopts the regimen described(2).
Among the chronic non-transmissable diseases 
which are responsible for chronic health conditions, 
Diabetes Mellitus (DM) stands out, because of its 
epidemic proportions on the national(3-4) and global 
scale(5), and the concept of adherence, for this disease, 
includes, as well as drug therapy, an individualized 
nutritional plan, regular physical exercise, and general 
care(6). Non-adherence to the therapeutic regimen 
contributes to poor metabolic control, resulting in acute 
and long-term complications(7).
Drug treatment for DM is complex and can involve 
different drugs with multiple dosages, as well as daily 
administration of exogenous insulin(6). The rates of 
adherence, in general, vary from 31% to 98%(8-12), and 
there is evidence that the more complex the therapeutic 
regimen, the lesser the adherence(7). In this regard, the 
literature has shown that adherence to the use of insulin 
is lower than adherence to the use of oral antidiabetics 
(OADs), with rates between 36% and 80% and from 
46.4% to 86%, respectively(7,13-15). This also suggests 
that adherence behaviors may not be related to each 
other, that is, people can adhere to one aspect of the 
treatment, but not to the other(7).
Another question which is relevant to adherence 
to treatment is how to measure it. It is difficult to 
determine an acceptable measurement of adherence 
due to this being a multi-dimensional concept, which 
can, moreover, be calculated by different methods, each 
with its advantages and limitations(16). The method used 
most for assessing adherence to treatment has been 
structured questionnaires, due to their simplicity and 
low cost, the fact that one obtains results immediately, 
and the possibility of detecting approximately 50% of 
people who do not adhere to the treatment regimen(1).
In Brazil, studies aiming to evaluate adherence to 
drug treatment for DM(9,12) and other chronic illnesses(17) 
have used the Measurement of Adherence to Treatments 
(MAT) questionnaire(18), an instrument which is accessible 
and easy to administer. Because this questionnaire was 
not developed exclusively for people with DM, however, 
it does not specifically cover adherence to OADs and 
insulin. Furthermore, instruments were not identified in 
the literature specifically evaluating these two aspects 
of the treatment.
Therefore, the present study aimed to verify the 
face validity and criterion-related validity, and the 
reliability of the MAT instrument, presented in two forms 
referent to the evaluation of adherence to the use of 
OADs and insulin, distinctly, and to assess whether there 
are differences in the scores for adherence between 
these two modes of drug therapy. 
Method
This is a cross-sectional and methodological study, 
undertaken in the outpatient department of a teaching 
hospital in the state of São Paulo (SP), in the period 
November 2010 – April 2011. 
The study’s sample was by convenience, selected 
through the weekly review of the medical records of the 
people scheduled for attendance with the health team, 
in line with the inclusion/exclusion criteria. The following 
were included: adults with Type 2 diabetes, of both sexes, 
being treated with insulin and OADs (monotherapy 
and/or in association with other therapies), who were 
able to maintain dialogs and who had an absence of 
chronic complications at advanced stages. People were 
excluded if they were receiving hemodialytic treatment, 
with amaurosis, had sequelae from cerebrovascular 
accidents/cardiac insufficiency, or were amputees or 
in wheelchairs. In addition to this, people unable to 
understand and/or verbalize responses to the interview 
questions were also withdrawn from the research. 
During the period in which the study was carried 
out, 492 people were attended in the above-mentioned 
outpatient department. Of these, 136 initially met the 
inclusion criteria. 17 people refused to participate, and 
five were excluded for the following reasons: dependence 
on oxygen, inability to communicate verbally, and 
amputation. A further 24 people did not respond to the 
request to participate. As a result, the sample was made 
up of 90 adults with DM2, a number which made it possible 
to carry out an initial evaluation of the questionnaires’ 
psychometric properties referring to the state of health, 
according to a systematic review study of quality criteria 
for evaluating this type of instrument’s properties(19).
People were invited to participate in the study 
verbally, in the waiting room, while they waited to be 
seen. After the presentation of the study’s objectives, 
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and clarifications on the anonymity of participation, the 
people were asked to indicate whether they agreed or 
not to participate in the study. Those who agreed were 
taken to a room set aside for data collection. The first 
item to be handed over was the Terms of Free and 
Informed Consent, which was read out loud by one of 
the researchers. Once it had been read, the participant 
was requested to sign it. 
For the collection of socio-demographic and 
clinical data, a semi-structured instrument was used, 
developed based on a previous study(12). The data 
referent to adherence to drug treatment was collected 
using the questionnaire Measurement of Adherence to 
Treatment (MAT)(18). This instrument had been adapted 
and validated in Portugal, with good internal consistency 
(Cronbach alpha coefficient of 0.74)(18), and was adapted 
for Brazilian Portuguese(9,12). The MAT is a scale made 
up of seven items and is for evaluating adherence to 
prescribed treatment with medications. All the items 
present a response pattern which goes from “always” to 
“never”, with scores varying, respectively, from one to six. 
The adherence is determined by the instrument’s global 
mean, that is, the scores for each item are summed and 
divided by the number of items (seven). Higher means 
indicate greater adherence to the treatment(18).
A previous study(12) using the MAT, in a sample of 162 
people with DM2 under outpatient treatment, showed 
that the instrument has acceptable reliability (Cronbach 
alpha of 0.66), according to a review study on the 
analysis of the psychometric properties of instruments 
for evaluating subjective phenomena, which considered 
values over 0.50 as reasonable(20).
Following the authors’ agreement(18), for the 
present study, this instrument’s questions relating to the 
modes of treatment were reviewed, giving rise to two 
ways of presenting the MAT; that is, one for evaluating 
the adherence to the drug therapy with OADs, and 
another, with insulin, respectively titled “Measurement 
of Adherence to Drug Therapy in Diabetes Mellitus – 
Oral Antidiabetics” (MAT OADs) and “Measurement of 
Adherence to Drug Therapy in Diabetes Mellitus – Insulin 
Therapy” (MAT insulin).
In the MAT OADs, the word “medications “ was 
substituted with “tablets” in all the items, apart from item 
5 (“Have you taken one or more tablets for diabetes, on 
your own initiative, because of feeling worse?”), which 
did not need changing, remaining identical to how it 
was in the original version. It is believed that the use of 
the word “tablets”, in all the items, may reflect a better 
standardization of the same.
Similarly, in the MAT insulin, the expression “take 
the medications” in items 1, 3, 4 and 7 was substituted 
with the expression “administer the insulin”; in item 2, 
the expression “time for taking the medications” was 
substituted with “time to administer the insulin”; in item 
5, “taken one or more tablets” was substituted with 
“administered one or more units of insulin”; and in item 
6, the expression “have let your medications run out” 
was substituted with “have let your insulin run out”.
It should be emphasized that no other term of 
the items was altered, so as to maintain the similarity 
with the original version, and not to de-characterise 
the instrument, given that it had been validated for the 
Portuguese language. 
For the face validity(21), the two forms of 
presentation of the MAT were submitted for approval by 
three health professionals who work in the area of care 
for people with DM, and the evaluation of each item’s 
relevance and clarity was requested. Following this, the 
researchers proceeded to the semantic analysis, the aim 
of which is to check if all the items are understandable 
for the target population(21). It is recommended that 
the understanding of the items should be verified with 
few subjects. The items are presented one-by-one and 
the subjects are requested to re-phrase them. If this is 
done without doubts, the item is correctly understood. 
Otherwise, the researcher must explain what is meant 
by the item in question, after which the respondents 
are requested to make suggestions such that the item 
may be reformulated(21). In this way, the two forms of 
the presentation of the MAT were administered to five 
people with this illness. 
For the criterion-related validity, the researchers 
proceeded to the ROC (Receiver Operating 
Characteristics) Curves, considering the original of the 
MAT as the gold standard criteria. 
The variables were submitted to the Komolgorov-
Smirnov and Levene tests for verification, respectively, 
of the variables’ normal distribution and homogeneity of 
the variances. 
These instruments’ reliability was evaluated through 
three methods: calculation of the Cronbach alpha 
coefficient for analysis of internal consistency; the item-
total correlation and the Pearson correlation co-efficient. 
The strength of the correlations was ascertained in 
accordance with the following classification: weak (r<0.3), 
moderate (0.3<r<0.6) and strong (r>0.6)(22).
The evaluation of the adherence was undertaken by 
measurements of central tendency (mean and median) 
and of the variability (standard deviation) of the final 
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scores and of the items of each one of the two forms, 
and their comparison was undertaken through the 
test for comparison of means (paired Student t test). 
The level of significance adopted was 0.05. The data 
collected was stored in the MS-Excel program, with 
double-keying, and validation of the same. Later, the 
database was exported to the Statistical Package for the 
Social Sciences (SPSS) program, version 17.0, for uni- 
and bivariate exploratory analysis. 
The present study was approved by the Research 
Ethics Committee of the Teaching Hospital of the Ribeirão 
Preto Faculty of Medicine, of the University of São Paulo, 
under process nº 9510/2010, and the mean length of 
the interviews was 61 minutes. 
Results
Socio-demographic and clinical characterization, 
and treatment of the sample
In the socio-demographic characterization of the 
sample, the mean age and respective standard deviation 
(SD) was 60 years (SD=8.05). Of the 90 participants, 
61 (67.8%) were female; 57 (63.3%) were married/
cohabiting and 74 (82.2%) were from Ribeirão Preto and/
or the surrounding region. Regarding occupation, there 
was a greater frequency of retired persons/pensioners 
(40%) followed by those who mentioned working in the 
home without payment (31.1%). The mean length of 
schooling was five years (SD=3.74).
Regarding the clinical and treatment-related 
variables, the time since diagnosis was, on average, 17.3 
years (SD=8.0); the mean length of use of OADs was 
10.9 years (SD=7.73), the daily frequency of use was, 
on average, 2.5 times per day (SD=0.64), and the most 
frequent class of medication (86.7%), irrespective of use 
in association with other OADs, was the biguanides. 
Regarding the use of insulin, the mean length of 
use was 8.6 years (SD=6.61), and the daily frequency 
of administration was, on average, 2.1 times per day 
(SD=0.57). The most frequently prescribed insulin 
schemes were human insulin NPH (43.3%) and the 
association of this last with regular insulin (53.3%).
Face and criterion-related validity and reliability of 
the MAT OADs and the MAT insulin
In the face validity, the specialists judged the 
two ways of presenting the MAT to be relevant to the 
purpose of the study. Because the original version of 
the instrument had been previously adapted to Brazilian 
Portuguese, further changes were not made. In relation 
to the semantic analysis, there were no difficulties in the 
re-phrasing of the items and, therefore, no suggestions 
for changes were made. 
Regarding the criterion-related validity, the MAT 
OADs presented an area under the curve of 0.83, 
sensitivity of 0.84, and specificity of 0.35. For the 
MAT insulin, the values were 0.77, 0.60, and 0.21 
respectively. (Figure 1).
Figure 1 - ROC Curves of the MAT OADs and the MAT insulin in the sample studied. Ribeirão Preto, SP, Brazil, 2011
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In the reliability analysis, evaluated using the 
Cronbach alpha coefficient (α), values were obtained of 
0.84 for the MAT OADs, and of 0.68 for the MAT insulin. 
In the MAT OADs, if item 2 is removed, the Cronbach 
alpha rises to 0.85, and in the MAT insulin, if this item 
is removed, it drops from 0.68 to 0.65. Remaining with 
the MAT insulin, the Cronbach alpha coefficient only 
increases (from 0.68 to 0.69) when item 6 is removed. 
In relation to the item-total correlations, values were 
obtained ranging from 0.38 to 0.77 for the MAT OADs, 
and from 0.20 to 0.53 for the MAT insulin (Table 1).
Table 1 - Cronbach alpha coefficient (α) and item-total correlation of the Measurement of Adherence to treatment – 
oral antidiabetics (MAT OADs) and of the Measurement of Adherence to Treatment – insulin (MAT insulin). Ribeirão 
Preto, SP, Brazil, 2011
Table 2 - Correlations between the items and the total of 
the Measurement of Adherence to the Treatment – oral 
antidiabetics (MAT OADs) and Measurement of Adherence 
to the Treatment – insulin (MAT insulin) scales, in the 
sample studied. Ribeirão Preto, SP, Brazil, 2011
*Pearson correlation †Statistical significance (p-value < 0.05)
In analyzing the reliability by means of the 
Pearson correlation coefficient, a statistically significant 
correlation with a strong magnitude was found between 
the final scores of the two forms of the instrument. 
There were statistically significant correlations, of weak 
and moderate magnitude, between the items of the 
MAT OADs and the MAT insulin. The results referent to 
the reliability analysis, undertaken through the three 
calculations, suggest that the forms proposed are 
reliable (Table 2).
Items of the forms of Measurement of
Adherence to Treatment (N = 90)
MAT OADs (α = 0.84) MAT insulin (α = 0.68)
Item-total 
correlation
Cronbach 
alpha if 
the item is 
removed
Item-total 
correlation
Cronbach 
alpha if 
the item is 
removed
1-Have you ever forgotten to take the tablets/ administer the insulin for the 
diabetes?
0.67 0.81 0.45 0.63
2-Have you ever been careless with the time for taking the tablets/administering 
the insulin for the diabetes?
0.53 0.83 0.41 0.65
3-Have you ever not taken the tablets/administered the insulin for the diabetes 
because of feeling better?
0.65 0.81 0.46 0.63
4-Have you ever not taken the tablets/administered the insulin for the diabetes, 
on your own initiative, because of feeling worse?
0.49 0.84 0.53 0.60
5-Have you ever taken one or more tablets/administered one or more units of 
insulin for the diabetes, on your own initiative, because of feeling worse?
0.38 0.85 0.38 0.65
6-Have you ever interrupted the treatment for diabetes because you had let the 
tablets/insulin run out?
0.76 0.80 0.20 0.69
7-Have you ever not taken the tablets/administered the insulin for the diabetes, 
for any reason apart from being so instructed by the doctor?
0.77 0.79 0.40 0.66
Items from the forms of Measurement of 
Adherence to Treatment r* (p-value)
Items 1 0.43 (0.000)†
Items 2 0.25 (0.002)†
Items 3 0.44 (0.000)†
Items 4 0.53 (0.000)†
Items 5 0.25 (0.020)†
Items 6 0.28 (0.000)†
Items 7 0.56 (0.000)†
Total of the Scales 0.77 (0.000)†
In the analysis of the adherence, the item with the 
lowest mean in both forms of the instrument was item 2. 
The highest means were for 5 (MAT OADs) and 7 (MAT 
insulin) (Table 3).
In undertaking the paired Student t-test, a 
statistically significant difference was found between 
the final scores of the two forms of the instrument, 
indicating greater adherence to the use of the insulin 
than to the OADs. In comparing the means of the items 
of the MAT OADs with the MAT insulin, there were also 
statistically-significant differences in items 1, 4, 6 and 
7 (Table 4).
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Items
Forms of the Instrument
MAT OADs (N=90) MAT insulin (N=90)
Mean (SD) Median (interval) Mean (SD) Median (interval)
1 5.06 (1.27) 6.00 (1.00-6.00) 5.50 (0.77) 6.00 (4.00-6.00)
2 4.87 (1.37) 5.00 (1.00-6.00) 5.04 (1.04) 5.00 (2.00-6.00)
3 5.62 (1.02) 6.00 (1.00-6.00) 5.71 (0.71) 6.00 (2.00-6.00)
4 5.27 (1.44) 6.00 (1.00-6.00) 5.71 (0.77) 6.00 (1.00-6.00)
5 5.71 (0.92) 6.00 (1.00-6.00) 5.57 (0.89) 6.00 (1.00-6.00)
6 5.56 (1.03) 6.00 (1.00-6.00) 5.80 (0.66) 6.00 (1.00-6.00)
7 5.61 (1.08) 6.00 (1.00-6.00) 5.89 (0.41) 6.00 (4.00-6.00)
Total of the scale 5.39 (0.84) 5.71 (1.71-6.00) 5.60 (0.45) 5.71 (4.00-6.00)
Items
Forms of the Instrument
Statistical value* p-value MAT OADs (N=90)
Mean (SD)
 
 
MAT insulin (N=90)
Mean (SD)
1 5.06 (1.27) 5.50 (0.77) 3.628 0.000†
2 4.87 (1.37) 5.04 (1.04) 1.127 0.263
3 5.62 (1.02) 5.71 (0.71) 0.882 0.380
4 5.27 (1.44) 5.71 (0.77) 3.459 0.000†
5 5.71 (0.92) 5.57 (0.89) -1.238 0.219
6 5.56 (1.03) 5.80 (0.66) 2.203 0.030†
7 5.61 (1.08)  5.89 (0.41) 2.889 0.005†
Total of the scale 5.39 (0.84) 5.60 (0.45) 3.578 0.001†
Table 3 - Description of the final scores and scores for each item in the Measurement of Adherence to the Treatment – 
oral antidiabetics (MAT OADs) and Measurement of Adherence to the Treatment – insulin (MAT insulin), in the sample 
studied. Ribeirão Preto, SP, Brazil, 2011
Table 4 - Comparison of the means of the final scores and of each item in the Measurement of Adherence to the 
Treatment – oral antidiabetics (MAT OADs) and of the Measurement of Adherence to the Treatment – insulin (MAT 
insulin), in the sample studied. Ribeirão Preto, SP, 2011
*Statistical value: paired Student t-test
†Statistical significance (p-value < 0.05)
Discussion
In relation to the socio-demographic characterization, 
the sample was made up of adults of low schooling 
and low incomes, retired, with a mean age of 60 years 
old, there being a majority of women (67.8%). These 
results are similar both to the original study in which the 
instrument was developed(18), and to those in which this 
instrument was adapted for Brazil(9,12,17).
In the criterion-related validity, the area under 
the curve was 0.83 and 0.77 for the MAT OADs and the 
MAT insulin, respectively. The area under the ROC curve 
is a measurement of the performance of a test, that 
is, it determines its exactitude. A test which is totally 
incapable of distinguishing adherent people and non-
adherent people would have an area under the curve 
of 0.5, which corresponds to the null hypothesis. Areas 
over 0.70 are considered satisfactory(23).
Regarding internal consistency, the Cronbach alpha 
values found were 0.84 and 0.68 for the MAT OADs and 
MAT insulin, respectively. Internal consistency is one of 
the ways of evaluating an instrument’s reliability(24), as 
it indicates the extent to which an instrument’s items 
are homogeneous, that is, are inter-correlated, thus 
measuring the same concept. The Cronbach alpha is 
considered a good measurement of internal consistency. 
Its value should vary from 0.70 to 0.95. This coefficient is 
sensitive to the instrument’s number of items, and for this 
reason higher values are commonly found in instruments 
with a greater number of items(19).
It may be observed that although the MAT 
instrument has only seven items, the value of the 
Cronbach alpha coefficient is found within an interval 
considered satisfactory by the literature(19). For the 
MAT insulin, this coefficient had a value below 0.70; 
however, according to the review study on analysis 
of the psychometric properties of instruments for 
assessing subjective phenomena, values over 0.50 are 
considered acceptable(20). It may also be observed that 
the two forms proposed in the present study present 
Cronbach alpha coefficients which are superior to those 
of the study of the adaptation of the MAT for the use of 
oral anticoagulants, where the value found was 0.60(17).
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When the alpha value was evaluated with the 
removal of each one of the items, a variation from 0.79 
to 0.85 was obtained for the MAT OADs, and from 0.60 to 
0.69 for the MAT insulin. In the original study in which the 
instrument (MAT original) was developed, the variation 
was from 0.69 to 0.73(19). The variation in the alpha value 
of the MAT OADs and MAT insulin was mildly greater than 
that of the MAT original. This data suggests that the items 
of these two forms of presentation of the instrument are 
as homogeneous as those of the original instrument. 
However, it is worth noting that the removal of the items 
did not significantly influence the Cronbach alpha values 
of the forms of presentation proposed in this study. In 
addition to this, the values obtained for the total of each 
scale are considered satisfactory and, for this reason, the 
instrument’s seven items have been maintained.
The item-total correlation is another measurement 
of an instrument’s reliability(24). In the present study, the 
values of the item-total correlations varied from 0.38 to 
0.77 for the MAT OADs and from 0.20 to 0.53 for the MAT 
insulin. It is desirable for the item-total correlation to be 
superior to 0.20. On the other hand, a high item-total 
correlation (> 0.80) can be indicative of redundancy(25). 
It may be observed that the item-total correlations were 
equal to or superior to 0.20, in the forms of presentation, 
suggesting that the administration of this instrument, 
separately, is reliable.
In the evaluation of the reliability using the 
Pearson correlation, the final scores of the two forms 
presented correlations of strong magnitude and which 
were statistically significant between each other, and 
each form’s items presented correlations which were 
statistically significant between each other, of weak and 
moderate magnitude. These findings suggest that the 
MAT OADs and MAT insulin are as reliable for evaluating 
the behavior of adherence as the MAT original.
Regarding adherence, the item with the lowest 
mean in both the forms of the instrument was item 2. 
This result suggests that in regard to the use of both 
OADs and insulin, the majority of the participants show 
the least adherence in regard to the time of day at which 
they use these medications. The items with the highest 
means were 5 (MAT OADs) and 7 (MAT insulin). This data 
shows that, for the OADs, the majority of the participants 
present adherence to the dosage prescribed, and that in 
relation to insulin therapy, the majority do not interrupt 
the use of insulin unless told to do so by their doctor. 
The final scores, on average, were 5.39 (SD=0.84) 
and 5.60 (SD=0.45) for the MAT OADs and MAT insulin, 
respectively. A statistically significant difference was 
observed between the means of the two forms’ final 
scores, with a higher mean for the MAT insulin, indicating 
greater adherence for this mode of treatment. This result 
differs from that of the systematic review study, which 
found a lower percentage of adherence among people 
under insulin therapy, when compared with those using 
OADs (73%; 86% respectively)(13). The greater adherence 
to insulin than to OADs in the sample studied may be 
attributed to the long time that the people involved had 
DM, as well as to the presence of its complications. In 
addition to this, the risk of hypoglycemia, associated with 
the use of insulin(6), can make the person administer the 
correct dose of this hormone.
When the means of the items between the two 
forms were compared, there were statistically significant 
differences in items 1, 4, 6 and 7, which shows greater 
adherence, in these items, for the MAT insulin.
 These last results suggest that in dealing with the 
use of OADs associated with insulin, instruments should 
be used which evaluate the adherence to these modes 
of treatment separately, because a single instrument 
cannot capture these differences. It is possible that in 
the sample studied, had a single instrument been used, 
adherence to the OADs could have been overestimated, 
due to the fact of the adherence to insulin being higher. 
Conclusion
The present study’s results allow one to consider 
that the two instruments, derived from the original 
version of the MAT, present psychometric properties 
which characterize them as reliable. 
The two forms of the presentation of the MAT 
made it possible to detect differences in adherence 
between the modes of drug treatment, showing there 
to be greater adherence to the insulin therapy than to 
the OADs – which might not be detected, were a single 
instrument to be used. It is therefore emphasized that 
for people with DM, separate instruments should be 
used to evaluate the adherence to treatment with OADs 
and to treatment with insulin.  
Some weak points, however, deserve to be 
considered. The small sample size may possibly not 
permit clinical validation of the instruments proposed, 
and may have limited the evaluation of their psychometric 
properties. The non-existence of instruments for 
assessing adherence to the two modes of drug therapy 
for DM separately both required the adaptation of an 
already-existing questionnaire, and made it difficult to 
compare the results.
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As a result of this, the replication of studies of this 
nature is recommended, with better methodological 
design, and in larger populational samples, so as to 
extend the psychometric analyses.
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